TrimRX
US$ 25.58
non-glp-1 medications GLP-1 use tripled among non-diabetics, reaching $5.8B in 2022 they view the product as a supportive tool for overall wellness rather than a magic weight Researchers find GLP-1 medications safe
Description
theyre also a window of opportunity for intervention
10.3390/life14060690 15
GLP-1RA use and thyroid cancer risk
Insurance companies are starting to balk at covering these drugs indefinitely (at $1,000-$1,500 per month)
PlexusDx patients receive personalized guidance on medication timing to prevent absorption problems
